Urology
Volume 61, Issue 4, Supplement 1 , Pages 26-33 , April 2003

Percutaneous computed tomography–guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results

  • L.i-Ming Su

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    • Corresponding Author InformationReprint requests: Li-Ming Su, MD, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, A-345, Baltimore, Maryland 21224, USA. E-mail: lsu11@jhmi.edu
    • ,
  • Thomas W. Jarrett

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    • ,
  • David Y. Chan

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    • ,
  • Louis R. Kavoussi

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    • ,
  • Stephen B. Solomon

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

References 

  1. Gill IS, Novick AC, Meraney AM, et al.  Laparoscopic renal cryoablation in 32 patients. Urology. 2000;56:748–753
  2. Zlotta AR, Wildschutz T, Raviv G, et al.  Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer (ex vivo and in vivo experience). J Endourol. 1997;11:251–258
  3. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma (impact of tumor size on patient survival, tumor recurrence and TNM staging). J Urol. 1999;162:1930–1933
  4. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma (10-year follow-up). J Urol. 2000;163:442–445
  5. Belldegrun A, Tsui KH, deKernion JB, et al.  Efficacy of nephron-sparing surgery for renal cell carcinoma (analysis based on the 1997 tumor-node-metastasis staging system). J Clin Oncol. 1999;17:2868–2875
  6. Wood TF, Rose DM, Chung M, et al.  Radiofrequency ablation of 231 unresectable hepatic tumors (indications, limitations, and complications). Ann Surg Oncol. 2000;7:593–600
  7. Livraghi T, Meloni F, Goldberg SN, et al.  Hepatocellular carcinoma (radio-frequency ablation of medium and large lesions). Radiology. 2000;214:761–768
  8. Curley SA, Izzo F, Delrio P, et al.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies (results in 123 patients). Ann Surg. 1999;230:1–8
  9. Rossi S, Garbagnati F, Lencioni R, et al.  Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119–126
  10. Pavlovich CP, Walther MM, Choyke PL, et al.  Percutaneous radiofrequency ablation of small renal tumors (initial results). J Urol. 2002;167:10–15
  11. Gervais DA, McGovern FJ, Wood BJ, et al.  Radio-frequency ablation of renal cell carcinoma (early clinical experience). Radiology. 2000;217:665–672
  12. Collyer WC, Landman J, Olweny EO, et al.  Comparison of renal ablation with cryotherapy, dry radiofrequency, and saline augmented radiofrequency in a porcine model. J Am Coll Surg. 2001;193:505–513
  13. Gill IS, Hsu THS, Fox RL, et al.  Laparoscopic and percutaneous radiofrequency ablation of the kidney (acute and chronic porcine study). Urology. 2000;56:197–200
  14. Michaels MJ, Rhee HK, Mourtzinos AP, et al.  Incomplete renal tumor destruction using radiofrequency interstitial ablation. J Urol. 2002;168:2406–2410
  15. Corwin TS, Lindberg G, Traxer O, et al.  Laparoscopic radiofrequency thermal ablation of renal tissue with and without hilar occlusion. J Urol. 2001;166:281–284
  16. Crowley JD, Shelton J, Iverson AJ, et al.  Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue (acute and chronic effects in an animal model). Urology. 2001;57:976–980
  17. Matlaga BR, Zagoria RJ, Woodruff RD, et al.  Phase II trial of radio frequency ablation of renal cancer (evaluation of the kill zone). J Urol. 2002;168:2401–2405
  18. Merkle EM, Shonk JR, Duerk JL, et al.  MR-guided RF thermal ablation of the kidney in a porcine model. Am J Roentgenol. 1999;173:645–651
  19. Ogan K, Jacomides L, Dolmatch BL, et al.  Percutaneous radiofrequency ablation of renal tumors (technique, limitations, and morbidity). Urology. 2002;60:954–958

PII: S0090-4295(03)00118-3

doi: 10.1016/S0090-4295(03)00118-3

Urology
Volume 61, Issue 4, Supplement 1 , Pages 26-33 , April 2003

Article Tools

* Image Usage & Resolution